您要查找的是不是:
- 脂溶性茶多酚中的主要活性組分及對人卵巢癌HO-8910細胞株的體外抑制活性The Main Active Component of Lipophilic Tea Polyphenols and in vitro Inhibition Activity on Ovarian Cancer Cells HO-8910
- 人卵巢癌HO-8910細胞HO-8910 cell
- 卵巢癌HO-8910細胞HO-8910 ovary carcinoma cell
- C-erbB-2與c-raf-1基因反義寡核苷酸聯(lián)合對人卵巢癌裸鼠皮下移植瘤的治療作用Therapeutic Effects of C-erbB-2 and C-raf-1 Gene Combined with Antisense Oligodeoxynucleotide on the Human Ovarian Carcinoma Transplanted Subcutaneously in Nude Mice
- TAM和DDP聯(lián)合用可有效抑制HO-8910細胞生長(cháng)及增殖。TAM combined with DDP suppressed the growth and proliferation of the cell HO-8910 efficiently.
- 免疫重建荷人卵巢癌嚴重聯(lián)合免疫缺陷鼠腹腔移植模型的建立Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice
- AZT作用后的 HO-8910細胞端粒酶活性明顯受抑制 ,且細胞的 G2 /M期 DNA含量明顯增高 .Telomerase activity of HO-8910 cells was significantly inhibited when treated with AZT, and cell cycle of treated HO-8910 cells was changed with marked increase in G 2/M phase.
- 人卵巢癌差異表達基因2human differentially expressed in ovarian cancer 2 gene (DOC-2)
- 人卵巢癌細胞human ovarian cancer cell line
- 免疫組化結果顯示:正常的HO一8910細胞FaS和Fas一L染色均為陰性; 而HO一8910一Fcy::Fur在加入5一FC4天后,Fas和Fas一L染色均為陽(yáng)性。The expression of Fas and FasL showed positive in HO-8910-Fcy::Fur after the 96 hours administration of 5-FC compared with negative in normal HO-8910 by immunohistochemical assay.
- 人卵巢上皮性腫瘤human epithelial ovarian tumor
- 卵巢癌p27ovarian carcinoma p27
- 人卵巢黃素化顆粒細胞生長(cháng)液對體外成熟小鼠卵母細胞皮質(zhì)顆粒分布的影響Effect of luteinized granulosa cell conditioned medium on cortical granule of mouse oocytes matured in vitro
- 卵巢癌基因1ovarian cancer gene 1 (OVCA1)
- 酸性成纖維細胞生長(cháng)因子在卵巢癌中的表達及其信號傳導途徑Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway
- 人卵巢上皮癌組織hOEC
- 卵巢癌耐藥細胞ovarian carcinoma drug-resistant cell
- 糖皮質(zhì)激素調節人卵巢癌細胞系HO-8910增殖、形態(tài)改變和粘附作用的分子機制The Mechanisms of Proliferation, Morphology and Adhesion Control in Human Ovarian Cancer Cell Lines HO-8910 by Glucocorticoids
- 上皮性卵巢癌Epithelial ovarian cancer
- 粘液性卵巢癌mucous ovarian cancer